P-GLYCOPROTEIN AND CYTOCHROME P450 GENOTYPE AND PHENOTYPE ON RESPONSE TO ANCA
P-糖蛋白和细胞色素 P450 基因型和表型对 ANCA 的反应
基本信息
- 批准号:7716797
- 负责人:
- 金额:$ 0.35万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-04-02 至 2008-05-31
- 项目状态:已结题
- 来源:
- 关键词:Computer Retrieval of Information on Scientific Projects DatabaseCyclophosphamideCytochrome P450EnzymesFundingGeneticGenotypeGlucocorticoidsGlycoproteinsGrantInstitutionPharmaceutical PreparationsPhenotypePurposeRenal functionResearchResearch PersonnelResourcesSourceUnited States National Institutes of Healthimprovedresearch studyresponse
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
The purpose of this research study is to determine whether genetic make-up of certain CYP450 enzymes and a particular drug transporter are significant to predicting responses (in terms of improved kidney function) to cyclophosphamide and glucocorticoid therapy.
这个子项目是许多研究子项目中的一个
由NIH/NCRR资助的中心赠款提供的资源。子项目和
研究者(PI)可能从另一个NIH来源获得了主要资金,
因此可以在其他CRISP条目中表示。所列机构为
研究中心,而研究中心不一定是研究者所在的机构。
本研究的目的是确定某些CYP 450酶和特定药物转运蛋白的遗传组成是否对预测环磷酰胺和糖皮质激素治疗的反应(在改善肾功能方面)具有重要意义。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MELANIE S JOY其他文献
MELANIE S JOY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MELANIE S JOY', 18)}}的其他基金
Diversification of Glomerular Kidney Disease Treatments By Targeting Therapeutics to the Kidney
通过针对肾脏的治疗来实现肾小球肾病治疗的多样化
- 批准号:
10808617 - 财政年份:2023
- 资助金额:
$ 0.35万 - 项目类别:
Drug Metabolizing Enzyme and Transporter Function in Chronic Kidney Disease
慢性肾病的药物代谢酶和转运蛋白功能
- 批准号:
8759210 - 财政年份:2014
- 资助金额:
$ 0.35万 - 项目类别:
Drug Metabolizing Enzyme and Transporter Function in Chronic Kidney Disease
慢性肾病的药物代谢酶和转运蛋白功能
- 批准号:
9329438 - 财政年份:2014
- 资助金额:
$ 0.35万 - 项目类别:
Drug Metabolizing Enzyme and Transporter Function in Chronic Kidney Disease
慢性肾病的药物代谢酶和转运蛋白功能
- 批准号:
9144405 - 财政年份:2014
- 资助金额:
$ 0.35万 - 项目类别:
PHARMACOGENIC REASONS FOR POOR LUPUS NEPHRITIS OUTCOMES
狼疮性肾炎预后不良的药理学原因
- 批准号:
7716807 - 财政年份:2008
- 资助金额:
$ 0.35万 - 项目类别:
P-GLYCOPROTEIN AND CYTOCHROME P450 GENOTYPE AND PHENOTYPE ON RESPONSE TO ANCA
P-糖蛋白和细胞色素 P450 基因型和表型对 ANCA 的反应
- 批准号:
7625574 - 财政年份:2006
- 资助金额:
$ 0.35万 - 项目类别:
PHARMACOGENIC REASONS FOR POOR LUPUS NEPHRITIS OUTCOMES
狼疮性肾炎预后不良的药理学原因
- 批准号:
7625587 - 财政年份:2006
- 资助金额:
$ 0.35万 - 项目类别:
PHARMACOGENIC REASONS FOR POOR LUPUS NEPHRITIS OUTCOMES
狼疮性肾炎预后不良的药理学原因
- 批准号:
7377537 - 财政年份:2005
- 资助金额:
$ 0.35万 - 项目类别:
P-GLYCOPROTEIN AND CYTOCHROME P450 GENOTYPE AND PHENOTYPE ON RESPONSE TO ANCA
P-糖蛋白和细胞色素 P450 基因型和表型对 ANCA 的反应
- 批准号:
7377524 - 财政年份:2005
- 资助金额:
$ 0.35万 - 项目类别:
相似海外基金
Optimization of Immunosuppressive Therapy Based on the Immunologic Mechanism of Hematopoietic Stem Cell Transplant with Post-transplant Cyclophosphamide
基于造血干细胞移植后环磷酰胺免疫机制优化免疫抑制治疗
- 批准号:
22K15561 - 财政年份:2022
- 资助金额:
$ 0.35万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Impact of ANCA Type and Rituximab vs. Cyclophosphamide on Cardiovascular Risk, Mortality, and Quality-Adjusted Life Years inANCA-Associated Vasculitis
ANCA 类型和利妥昔单抗与环磷酰胺对 ANCA 相关性血管炎的心血管风险、死亡率和质量调整生命年的影响
- 批准号:
10292270 - 财政年份:2021
- 资助金额:
$ 0.35万 - 项目类别:
Measurement of urinary and salivary cyclophosphamide of hospital staff and verification of guidelines for measures against exposure to anticancer drugs
医院工作人员尿液和唾液环磷酰胺的测定以及抗癌药物暴露措施指南的验证
- 批准号:
20H03969 - 财政年份:2020
- 资助金额:
$ 0.35万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Resarch on prevention of cyclophosphamide cardiotocity by removing acrolein
去除丙烯醛预防环磷酰胺强心死亡的研究
- 批准号:
20K08232 - 财政年份:2020
- 资助金额:
$ 0.35万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Pharmacokinetics of post-transplant cyclophosphamide and its active metabolite for pediatric hematopoietic stem cell transplantation
移植后环磷酰胺及其活性代谢物在小儿造血干细胞移植中的药代动力学
- 批准号:
19K17316 - 财政年份:2019
- 资助金额:
$ 0.35万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanism leading to abnormal teeth and craniosynostosis by administration of cyclophosphamide
阐明环磷酰胺导致牙齿异常和颅缝早闭的机制
- 批准号:
19K24091 - 财政年份:2019
- 资助金额:
$ 0.35万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Impact of ANCA Type and Rituximab vs. Cyclophosphamide on Cardiovascular Risk, Mortality, and Quality-Adjusted Life Years inANCA-Associated Vasculitis
ANCA 类型和利妥昔单抗与环磷酰胺对 ANCA 相关性血管炎的心血管风险、死亡率和质量调整生命年的影响
- 批准号:
9886161 - 财政年份:2018
- 资助金额:
$ 0.35万 - 项目类别:
Impact of ANCA Type and Rituximab vs. Cyclophosphamide on Cardiovascular Risk, Mortality, and Quality-Adjusted Life Years inANCA-Associated Vasculitis
ANCA 类型和利妥昔单抗与环磷酰胺对 ANCA 相关性血管炎的心血管风险、死亡率和质量调整生命年的影响
- 批准号:
10372989 - 财政年份:2018
- 资助金额:
$ 0.35万 - 项目类别:
Metabolic signatures of triple negative breast cancer sensitivity and resistance to cyclophosphamide and doxorubicin in patient derived tumor xenografts
患者来源的肿瘤异种移植物中三阴性乳腺癌对环磷酰胺和阿霉素的敏感性和耐药性的代谢特征
- 批准号:
376831 - 财政年份:2017
- 资助金额:
$ 0.35万 - 项目类别:
Fellowship Programs
Randomized Controlled Trial of Olanzapine for the Control of Chemotherapy-induced Vomiting in Children Receiving Cyclophosphamide-based Conditioning for Allogeneic Hematopoietic Stem Cell Transplant
奥氮平控制接受基于环磷酰胺的同种异体造血干细胞移植调理的儿童化疗引起的呕吐的随机对照试验
- 批准号:
370131 - 财政年份:2017
- 资助金额:
$ 0.35万 - 项目类别:
Operating Grants














{{item.name}}会员




